Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
Belantamab Mafodotin治疗复发/难治性多发性骨髓瘤（RRMM）的真实世界结果：西班牙扩大用药计划（EAP）的初步结果
期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-022-00212-5
Alegre, Adrián; Benzo, Gonzalo; Alonso, Rafael; Martínez-López, Joaquín; Jimenez-Ubieto, Ana; Cuéllar, Clara; Askari, Elham; Prieto, Elena; Aláez, Concepción; Aguado, Beatriz; Velasco, Alberto; Krsnik, Isabel; Bocanegra, Ana; Llorente, Laura; Muñoz-Linares, Cristina; Morales, Ana; Giménez, Eugenio; Iglesias, Rebeca; Martínez-Chamorro, Carmen; Alonso, Aránzazu; Jiménez-Montes, Carmen; Blanchard, María J
